m.coelho

TL2 Moderator · Łódź

Contributes reviews on supplier material. Based in Łódź.

Joined 18 August 2025 · last posted 8d

85 posts, newest first. Showing up to 150.

Priming a pen and whether the primed volume is wasted Replied, post #14 · Devices › Pens & autoinjectors · 20 Jul 2026 · 2 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #62 · Start Here › Welcome · 20 Jul 2026 · 1 like post #61 answers the question as asked. The question underneath it is different. Welcome. The orientation materials are pinned at the top of this category and they take…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #81 · Wellbeing › Sleep · 10 Jul 2026 · 15 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
Submitting a sample: the process end to end Replied, post #66 · Sourcing › Independent verification · 8 Jul 2026 · 27 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #3 · Compounds › Repair & healing peptides · 7 Jul 2026 · 1 like For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #34 · Practice › Dosing & titration · 3 Jul 2026 · 31 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #8 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #89 · Start Here › How to Ask · 2 Jul 2026 · 1 like post #88 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #52 · Evidence › Journal club · 28 Jun 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Athletes in weight-category sports: a different risk calculus Replied, post #3 · Clinical › Special populations · 25 Jun 2026 · 16 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #25 · Analytics › Home & field testing · 24 Jun 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #12 · Compounds › Retatrutide · 22 Jun 2026 · 8 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Racemisation and why it is invisible to a mass measurement Replied, post #18 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #87 · Sourcing › Red flags · 6 Jun 2026 · 1 like Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
A checklist for reading a certificate in under two minutes Replied, post #33 · Analytics › COA interpretation · 3 Jun 2026 · 0 likes This follows post #30 rather than contradicting it. When a document puts the specification in the result column, it has told you the release criterion, not the…
Bariatric surgery history: altered anatomy, altered expectations Replied, post #27 · Clinical › Special populations · 27 May 2026 · 10 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Micro-titration: a disputed topic, argued properly Replied, post #79 · Practice › Dosing & titration · 24 May 2026 · 6 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Tracking a shortage from primary sources rather than rumour Replied, post #10 · Access › Shortages · 15 May 2026 · 22 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #69 · Evidence › Trials · 2 May 2026 · 10 likes post #68 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #34 · Practice › Administration · 30 Apr 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #8 · Sourcing › Independent verification · 29 Apr 2026 · 10 likes On post #4 — agreed on the reasoning, with one qualification. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports…
Coming back to: Measurement error in a self-reported exposure Replied, post #9 · Evidence › Study critique · 22 Apr 2026 · 3 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #114 · Clinical › Special populations · 17 Apr 2026 · 28 likes Worth separating two things that post #110 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
CJC-1295 with and without DAC: what the modification does Replied, post #34 · Compounds › Secretagogues & GH axis · 15 Apr 2026 · 2 likes post #33 is right about the mechanism and I think understates the practical bit. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #8 · Practice › Reconstitution · 14 Apr 2026 · 15 likes Picking up post #5: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing.…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #82 · Compounds › Tirzepatide · 14 Apr 2026 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Why the timeline is on the right and not the left — what changed since Replied, post #18 · Meta › Site feedback · 10 Apr 2026 · 29 likes Coming back to post #16, because the follow-up matters more than the original answer. Navigation problems: if you cannot find something you expected to exist, or the…
Revisiting: Drawing up with one needle and injecting with another Replied, post #67 · Practice › Administration · 7 Apr 2026 · 11 likes Coming back to post #65, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
The "under review" status pill and when a moderator applies it Replied, post #36 · Evidence › Preprints · 25 Mar 2026 · 19 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Blinding yourself: practical methods and their limits Replied, post #13 · Research Methods › N-of-1 designs · 24 Mar 2026 · 0 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
Preprint servers and what screening they do Replied, post #85 · Evidence › Preprints · 11 Mar 2026 · 16 likes Worth separating two things that post #81 runs together. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #15 · Sourcing › Red flags · 11 Mar 2026 · 0 likes Picking up post #12: that is the part I would want checked first. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
Amylin receptor signalling and satiety — what changed since Replied, post #24 · Pharmacology › Receptor biology · 1 Feb 2026 · 0 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
Designing a personal experiment that could change your mind — one year on Replied, post #5 · Research Methods › N-of-1 designs · 25 Jan 2026 · 0 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
MHRA statements, read directly Replied, post #71 · Regional › UK & Ireland · 19 Jan 2026 · 16 likes Picking up post #68: that is the part I would want checked first. Importing for personal use: importing a prescription-only medicine without a prescription is not…
Constipation management, with a dietitian's contribution Replied, post #19 · Practice › Side effects · 14 Jan 2026 · 1 like I read post #17 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Personal import allowances, compared — a second dataset Replied, post #51 · Access › International · 13 Jan 2026 · 2 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #11 · Pharmacology › Pharmacokinetics · 8 Jan 2026 · 14 likes I read post #9 twice before replying, because I had assumed the opposite. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #73 · Compounds › Tirzepatide · 10 Dec 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
What a purity-only report leaves out Replied, post #103 · Sourcing › Independent verification · 26 Nov 2025 · 7 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
What a reversed-phase purity number actually is — the long version Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 23 Nov 2025 · 9 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #51 · Practice › Interactions · 16 Nov 2025 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #12 · Sourcing › Regulatory · 2 Nov 2025 · 1 like Picking up post #9: that is the part I would want checked first. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy…
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #5 · Compounds › Tirzepatide · 30 Oct 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
EMA product information as a primary source Replied, post #7 · Regional › European Union · 27 Oct 2025 · 14 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #58 · Practice › Reconstitution · 21 Sep 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #128 · Access › Insurance & coverage · 21 Sep 2025 · 3 likes post #127 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #57 · Compounds › Semaglutide · 12 Sep 2025 · 30 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Hypertension improvement and when medication needs revisiting Replied, post #55 · Clinical › Comorbidities · 12 Sep 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #38 · Compounds › Tirzepatide · 30 Aug 2025 · 1 like Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #99 · Compounds › Tirzepatide · 3 Aug 2025 · 15 likes This follows post #96 rather than contradicting it. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #11 · Devices › Pens & autoinjectors · 20 Jul 2025 · 4 likes On post #7 — agreed on the reasoning, with one qualification. Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g.,…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #134 · Compounds › Tirzepatide · 12 Jul 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Sequence verification for an obscure compound: how it is done Replied, post #89 · Compounds › Other compounds · 11 Jul 2025 · 12 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Regional warehouse stock versus direct despatch Replied, post #3 · Sourcing › Logistics · 11 Jun 2025 · 30 likes This follows post #2 rather than contradicting it. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 24 May 2025 · 15 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #46 · Devices › Pens & autoinjectors · 22 May 2025 · 10 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
Pregnancy as an absolute contraindication Replied, post #71 · Safety › Contraindications · 19 May 2025 · 10 likes post #70 answers the question as asked. The question underneath it is different. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #34 · Evidence › Journal club · 18 May 2025 · 1 like Picking up post #31: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
A report I filed that turned out to be wrong, and the correction Replied, post #51 · Sourcing › Vendor reports · 13 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: German, French and Dutch differences, compared Replied, post #20 · Regional › European Union · 10 May 2025 · 10 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
Holding a dose indefinitely: is there a documented downside? Replied, post #19 · Practice › Dosing & titration · 27 Apr 2025 · 33 likes I read post #17 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
Relative retention time as a better inter-laboratory comparator Started this topic · Analytics › Method validation · 9 Apr 2025 · 18 likes On the subject in the title: Relative retention time as a better inter-laboratory comparator Working notes rather than a conclusion. Posting the method first, because I…
Follow-up: Open-label extensions: what survives and what does not Replied, post #20 · Evidence › Trials · 27 Mar 2025 · 16 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Maintainer handover: how it works Replied, post #71 · Meta › Wiki maintenance · 18 Mar 2025 · 28 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #76 · Compounds › Cagrilintide & amylin analogues · 6 Mar 2025 · 24 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
Consistent declarations and why they matter more than clever ones Replied, post #47 · Sourcing › Logistics · 17 Feb 2025 · 23 likes I read post #45 twice before replying, because I had assumed the opposite. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #34 · Practice › Reconstitution · 16 Feb 2025 · 4 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #83 · Evidence › Meta-analyses · 9 Feb 2025 · 9 likes post #82 answers the question as asked. The question underneath it is different. Number needed to treat from a meta-analysis: can be computed from the pooled estimate…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #49 · Devices › Cold chain · 9 Feb 2025 · 20 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
Ipamorelin selectivity claims and where they came from Replied, post #11 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 19 likes Picking up post #8: that is the part I would want checked first. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in…
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #9 · Devices › Pens & autoinjectors · 14 Jan 2025 · 15 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
Reading a supplementary appendix and finding the interesting part Replied, post #59 · Evidence › Trials · 4 Jan 2025 · 22 likes This follows post #56 rather than contradicting it. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #6 · Compounds › Oral incretins · 25 Dec 2024 · 3 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Building a sensible monitoring schedule with your prescriber Replied, post #90 · Clinical › Bloodwork · 22 Dec 2024 · 9 likes post #89 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #31 · Sourcing › Regulatory · 17 Nov 2024 · 0 likes post #30 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #49 · Compounds › Repair & healing peptides · 13 Nov 2024 · 0 likes Picking up post #46: that is the part I would want checked first. The distinction between "no evidence it works" and "evidence it does not work": we have the first for…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #90 · Compounds › Other compounds · 3 Nov 2024 · 0 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #19 · Practice › Administration · 10 Sep 2024 · 27 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
Second pass at: Reimbursement variation across member states Replied, post #6 · Regional › European Union · 4 Sep 2024 · 2 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
Pen wastage and its effect on real cost Replied, post #20 · Access › Pricing · 30 Aug 2024 · 2 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
Guidelines revision: what changed and why Replied, post #29 · Meta › Announcements · 25 Jul 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
How this community labels and discusses unrefereed work Replied, post #110 · Evidence › Preprints · 24 Jul 2024 · 0 likes post #109 is right about the mechanism and I think understates the practical bit. Check whether it was later published: searching for the preprint's first author and…
Blind submission and why it changes minds Replied, post #16 · Sourcing › Independent verification · 16 Jul 2024 · 3 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Where the four-week escalation interval comes from, and what it is not Replied, post #18 · Practice › Dosing & titration · 11 Jun 2024 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…